10-92239511-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_014912.5(CPEB3):c.840C>T(p.Val280=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00302 in 1,574,952 control chromosomes in the GnomAD database, including 126 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.016 ( 62 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 64 hom. )
Consequence
CPEB3
NM_014912.5 synonymous
NM_014912.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.319
Genes affected
CPEB3 (HGNC:21746): (cytoplasmic polyadenylation element binding protein 3) Enables mRNA 3'-UTR binding activity and translation factor activity, RNA binding. Involved in cellular response to amino acid stimulus; negative regulation of transcription by RNA polymerase II; and positive regulation of mRNA catabolic process. Located in several cellular components, including cytosol; midbody; and nucleoplasm. Part of CCR4-NOT complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 10-92239511-G-A is Benign according to our data. Variant chr10-92239511-G-A is described in ClinVar as [Benign]. Clinvar id is 785323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.319 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0538 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CPEB3 | NM_014912.5 | c.840C>T | p.Val280= | synonymous_variant | 2/10 | ENST00000265997.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CPEB3 | ENST00000265997.5 | c.840C>T | p.Val280= | synonymous_variant | 2/10 | 1 | NM_014912.5 | ||
CPEB3 | ENST00000412050.8 | c.840C>T | p.Val280= | synonymous_variant | 2/10 | 1 | P1 | ||
CPEB3 | ENST00000614585.4 | c.840C>T | p.Val280= | synonymous_variant | 2/10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0158 AC: 2406AN: 152156Hom.: 62 Cov.: 32
GnomAD3 genomes
AF:
AC:
2406
AN:
152156
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00410 AC: 751AN: 183054Hom.: 16 AF XY: 0.00310 AC XY: 303AN XY: 97634
GnomAD3 exomes
AF:
AC:
751
AN:
183054
Hom.:
AF XY:
AC XY:
303
AN XY:
97634
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00165 AC: 2346AN: 1422678Hom.: 64 Cov.: 31 AF XY: 0.00141 AC XY: 989AN XY: 703878
GnomAD4 exome
AF:
AC:
2346
AN:
1422678
Hom.:
Cov.:
31
AF XY:
AC XY:
989
AN XY:
703878
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0158 AC: 2410AN: 152274Hom.: 62 Cov.: 32 AF XY: 0.0156 AC XY: 1162AN XY: 74468
GnomAD4 genome
AF:
AC:
2410
AN:
152274
Hom.:
Cov.:
32
AF XY:
AC XY:
1162
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 24, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at